WebSeekyo is a biotechnology company developing the next generation of targeted therapy for solid cancer: TUMOR ACTIVATED THERAPY We aim at a high selectivity in the treatment … WebCSO, co-founder +33 (0)6 88 52 27 25 Dr. Brigitte Renoux Medicinal Chemistry Dr. Jean-Louis Brayer Production, CMC Dr. Jean-Pierre Bizzari Clinical Development Dr. Jaques Medioni Clinical Pharmacology Contact Seekyo Technopole Grand Poitiers Site CEI - bat. … Seekyo is adding diagnostics and theranostics capabilities to its lead … The next generation of targeted therapy for solid cancer The next generation of targeted therapy for solid cancer
SEEKYO Therapeutics Management Team Org Chart
WebSeekyo is a biotechnology company developing the next generation of targeted therapy for solid cancer: TUMOR ACTIVATED THERAPYWe aim at a high selectivity in the treatment … WebContact Email [email protected] Seekyo is a privately-owned biotech company that develops the next generation of chemotherapies By targeting the … finlay road
Regulus Therapeutics Announces $15 Million Private Placement …
WebApr 14, 2024 · Esperion Therapeutics Inc (ESPR) stock is trading at $1.21 as of 11:29 AM on Friday, Apr 14, a drop of -$0.14, or -10.37% from the previous closing price of $1.35. The stock has traded between $1.21 and $1.35 so far today. Volume today is light. WebGet Sébastien Papot's email address (s*****@seekyo-therapeutics.com) and phone number (+33 6 88 52 2....) at RocketReach. Get 5 free searches. ... Find contact details for 700 million professionals. Search. People Like Sébastien Papot . Aurélien WAHDY Responsable d'Affaires. Poitiers, Poitou-Charentes, France Web2 days ago · Regulus Therapeutics Inc. (Nasdaq: RGLS) is a biopharmaceutical company focused on the discovery and development of innovative medicines targeting microRNAs. Regulus has leveraged its ... eso enable out of date addons